There are reports of progress in lung cancer biomarker testing, with some outlets discussing advancements and others highlighting gaps in access and treatment selection. However, some headlines appear to be focused on different types of cancer, such as prostate cancer and breast cancer, which may indicate a broader discussion about cancer treatment and research. The exact nature and scope of the developments in lung cancer biomarker testing are unclear.